The effects of the nitric oxide synthase inhibitor, Nw-nitro-L-arginine methyl ester (L-NAME) were investigated in two animal models of anxiety: the elevated plus-maze and the social interaction test. In the elevated plus- maze, L-NAME (12.5-50 mg/kg) had an anxiogenic-like profile as indicated by dose-dependent reductions in the time spent on the open arms, open arm entries, the percentage of open arm entries and head dips, but there was no significant effect on the number of stretch attend postures. In contrast, L-NAME (12.5-50 mg/kg) failed to modify time spent in social interaction but did reduce a measure of vertical activity The differential effects of L-NAME in the two anxiety paradigms are discussed.
Bannerman D.M., Chapman P.F., Kelly PA, Butcher S.P.Morris R.G. (1994) Inhibition of nitric oxide synthesis does not prevent the induction of long-term potentiation in vivo. J Neurosci14: 7415-7425
2.
Bruhwyler J., Chleide E., Liegeois J.F., Carreer F. (1993) Nitric oxide: a new messenger in the brain. Neurosci Biobehav Rev17: 373-378
3.
Caton PW, Tousman SA, Quock RM (1994) Involvement of nitric oxide in nitrous oxide anxiolysis in the elevated plus-maze. Pharmac Biochem Behav48: 689-692
4.
Cole J.C., Rodgers R.J. (1993) An analysis of the effect of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav Pharmac4: 573-580
5.
Critchley M A E, Handley S.C. (1987) 5-HT1A ligand effects in the X-maze anxiety test. Br J Pharmac92: 660P
6.
Davis M., Redmond DE Jr, Baraban J.M. (1979) Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology65: 111-118
7.
Davis M., Cassella J.V., Kehne J.M. (1988) Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 6-OH-DPAT and ipsapirone. Psychopharmacology94:14-20
8.
Dunn R.W., Corbett R., Fielding S. (1989) Effects of 5-HT1a receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus-maze. Eur J Pharmac169: 1-10
9.
Dwyer M.A., Bredt D.S., Snyder S.H. (1991) Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo. Biochem Biophys Res Comm176:1136-1141
10.
Estall L.B., Grant S.J., Cicela G.A. (1993) Inhibition of nitric oxide selectively impairs learning and memory in the rat. Pharmac Biochem Behav46: 959-962
11.
File S.E. (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Meth2: 219-238
12.
File S.E., Hyde J R G (1978) Can social interaction be used to measure anxiety ? Br J Pharmac62: 19-24
13.
File S.E., Gonzalez L.E., Andrews N. (1996) Comparative study of pre-and postsynaptic 5-HT 1A receptor modulation of anxiety in two ethological animal tests. J Neurosci16: 4810-4815
14.
Gardner C.R., GuyA PA ( 1984) A social interaction model of anxiety sensitive to acutely administered benzodiazepines. Drug Dev Res4: 207-216
15.
Garthwaite J., Charles S.L., Chess-Williams R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests a role as intercellular messenger in brain. Nature336: 385-388
16.
Gonzalez L.E., Andrews N., File S.E. (1996) 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus maze. Brain Res732: 145-153
17.
Guimaraes F.S., de Aguiar J.C., Bel E A D, Ballejo G. (1994) Anxiolytic effect of nitric oxide synthase inhibitors microinjected into the dorsal central grey. NeuroReport5:1929-1932
18.
Palmer R M J, Ferrige A.G., Moncada S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature327: 524-526
19.
Pellow S., Chopin P., File S.E., Briley M. (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth14:149-167
20.
Quack RM, Nguyen E. (1992) Possible involvement of nitric oxide in chlordiazepoxide-induced anxiolysis in mice. Life Sci51: 255-260
21.
Rodgers R.J., Cole J.C., Cobain M.R., Daly P., Eells J.R., Wallis P. (1992) Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B , TFMPP and mCPP Behav Pharmac3: 621-634
22.
Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourish C.T. (1994) Behavioural and pharmacological characteristics of the elevated 'zero-maze' as a model of anxiety. Psychopharmacology16: 56-64
23.
Soderpalm B., Engel JA (1988) Biphasic effects of clonidine on conflict behaviour: involvement of different alpha-adrenoceptors. Pharmac Biochem Behav30: 471-477
24.
Treit D., Menard J., Royan C. (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmac Biochem Behav44: 463-469
25.
Vale A.L., Montgomery A M J (1997) Social interaction: responses to chlordiazepoxide and the loss of isolation-reared effects with paired-housing. Psychopharmacology, 133: 127-132
26.
VolkeV., Koks S.,Vasar E., Bourin M., Bradwejn J., Mannisto P.T. (1995) Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. NeuroReport6: 1285-1288
